Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women

Background— The influence of systolic and diastolic blood pressure (BP) on incident atrial fibrillation (AF) is not well studied among initially healthy, middle-aged women. Methods and Results— A total of 34 221 women participating in the Women's Health Study were prospectively followed up for incident AF. The risk of AF across categories of systolic and diastolic BP was compared by use of Cox proportional-hazards models. During 12.4 years of follow-up, 644 incident AF events occurred. Using BP measurements at baseline, we discovered that the long-term risk of AF was significantly increased across categories of systolic and diastolic BP. Multivariable-adjusted hazard ratios for systolic BP categories (<120, 120 to 129, 130 to 139, 140 to 159, and ≥160 mm Hg) were 1.0, 1.00 (95% CI, 0.78 to 1.28), 1.28 (95% CI, 1.00 to 1.63), 1.56 (95% CI, 1.22 to 2.01), and 2.74 (95% CI, 1.77 to 4.22) (P for trend <0.0001). Adjusted hazard ratios across baseline diastolic BP categories (<65, 65 to 74, 75 to 84, 85 to 89, 90 to 94, and ≥95 mm Hg) were 1.0, 1.17 (95% CI, 0.81 to 1.69), 1.18 (95% CI, 0.84 to 1.65), 1.53 (95% CI, 1.05 to 2.23), 1.35 (95% CI, 0.82 to 2.22), and 2.15 (95% CI, 1.21 to 3.84) (P for trend=0.004). When BP changes over time were accounted for in updated models, multivariable-adjusted hazard ratios were 1.0, 1.14 (95% CI, 0.89 to 1.46), 1.37 (95% CI, 1.07 to 1.76), 1.71 (95% CI, 1.33 to 2.21), and 2.21 (95% CI, 1.45 to 3.36) (P for trend <0.0001) for systolic BP categories and 1.0, 1.12 (95% CI, 0.82 to 1.52), 1.13 (95% CI, 0.83 to 1.52), 1.30 (95% CI, 0.89 to 1.88), 1.50 (95% CI, 1.01 to 1.88), and 1.54 (95% CI, 0.75 to 3.14) (P for trend=0.026) for diastolic BP categories. Conclusions— In this large cohort of initially healthy women, BP was strongly associated with incident AF, and systolic BP was a better predictor than diastolic BP. Systolic BP levels within the nonhypertensive range were independently associated with incident AF even after BP changes over time were taken into account.

[1]  B. Gersh.  Myocardial Infarction and Risk of Suicide: A Population-Based Case-Control Study , 2011 .

[2]  T. Lehtimäki,et al.  Lifetime Fruit and Vegetable Consumption and Arterial Pulse Wave Velocity in Adulthood: The Cardiovascular Risk in Young Finns Study , 2010, Circulation.

[3]  R. Vasan,et al.  Exhaled Carbon Monoxide and Risk of Metabolic Syndrome and Cardiovascular Disease in the Community , 2010, Circulation.

[4]  Na Wang,et al.  Hemodynamic Correlates of Blood Pressure Across the Adult Age Spectrum: Noninvasive Evaluation in the Framingham Heart Study , 2010, Circulation.

[5]  Deepak L. Bhatt,et al.  Attained Educational Level and Incident Atherothrombotic Events in Low- and Middle-Income Compared With High-Income Countries , 2010, Circulation.

[6]  W. März,et al.  Homoarginine, Cardiovascular Risk, and Mortality , 2010, Circulation.

[7]  E. Benjamin,et al.  Aortic Root Remodeling Over the Adult Life Course: Longitudinal Data From the Framingham Heart Study , 2010, Circulation.

[8]  E. Benjamin,et al.  Correlates of Echocardiographic Indices of Cardiac Remodeling Over the Adult Life Course: Longitudinal Observations From the Framingham Heart Study , 2010, Circulation.

[9]  L. Vatten,et al.  Hypertension in Pregnancy and Later Cardiovascular Risk: Common Antecedents? , 2010, Circulation.

[10]  Andrew D. Johnson,et al.  Relation of Platelet and Leukocyte Inflammatory Transcripts to Body Mass Index in the Framingham Heart Study , 2010, Circulation.

[11]  L. Groop,et al.  Plasma Copeptin and the Risk of Diabetes Mellitus , 2010, Circulation.

[12]  G. Jensen,et al.  Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study , 2010, Circulation.

[13]  I. D. de Boer,et al.  Urinary Creatinine Excretion Rate and Mortality in Persons With Coronary Artery Disease: The Heart and Soul Study , 2010, Circulation.

[14]  P. Wolf,et al.  Parental Occurrence of Stroke and Risk of Stroke in Their Children: The Framingham Study , 2010, Circulation.

[15]  V. Barrios,et al.  Letter by Barrios et al regarding article, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women". , 2010, Circulation.

[16]  P. Volberding,et al.  Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected Persons , 2010, Circulation.

[17]  D. Lloyd‐Jones,et al.  Burden of Cardiovascular Risk Factors, Subclinical Atherosclerosis, and Incident Cardiovascular Events Across Dimensions of Religiosity: The Multi-Ethnic Study of Atherosclerosis , 2010, Circulation.

[18]  D. McManus,et al.  Longitudinal Tracking of Left Atrial Diameter Over the Adult Life Course: Clinical Correlates in the Community , 2010, Circulation.

[19]  U. Goldbourt,et al.  Neighborhood Socioeconomic Context and Long-Term Survival After Myocardial Infarction , 2010, Circulation.

[20]  T. Laitinen,et al.  Arterial Structure and Function After Recovery From the Metabolic Syndrome: The Cardiovascular Risk in Young Finns Study , 2010, Circulation.

[21]  J. Tuomilehto,et al.  Joint Effects of Physical Activity, Body Mass Index, Waist Circumference, and Waist-to-Hip Ratio on the Risk of Heart Failure , 2010, Circulation.

[22]  Elia Biganzoli,et al.  Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.

[23]  B. Gersh.  Declining Severity of Myocardial Infarction From 1987 to 2002: The Atherosclerosis Risk in Communities (ARIC) Study , 2010 .

[24]  M. Pencina,et al.  Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community , 2009, Circulation.

[25]  S. Yusuf,et al.  Differential Clinical Outcomes Associated With Hypoglycemia and Hyperglycemia in Acute Myocardial Infarction , 2009, Circulation.

[26]  D. Levy,et al.  Relations of Lipid Concentrations to Heart Failure Incidence: The Framingham Heart Study , 2009, Circulation.

[27]  C. Dethlefsen,et al.  Anthropometry, Body Fat, and Venous Thromboembolism: A Danish Follow-Up Study , 2009, Circulation.

[28]  M. Pfeffer,et al.  Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality , 2009, Circulation.

[29]  A. Algra,et al.  Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease , 2009, Circulation.

[30]  S. Sawada,et al.  Perioperative Risk Predictors of Cardiac Outcomes in Patients Undergoing Liver Transplantation Surgery , 2009, Circulation.

[31]  D. Levy,et al.  Association of Leukocyte Telomere Length With Echocardiographic Left Ventricular Mass: The Framingham Heart Study , 2009, Circulation.

[32]  P. Ridker,et al.  Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women: A Prospective Study , 2009, Circulation.

[33]  P. Vokonas,et al.  A Prospective Study of Bone Lead Concentration and Death From All Causes, Cardiovascular Diseases, and Cancer in the Department of Veterans Affairs Normative Aging Study , 2009, Circulation.

[34]  L. Ferrucci,et al.  Pathophysiological Changes in Calf Muscle Predict Mobility Loss at 2-Year Follow-Up in Men and Women With Peripheral Arterial Disease , 2009, Circulation.

[35]  Roger D. Peng,et al.  Emergency Hospital Admissions for Cardiovascular Diseases and Ambient Levels of Carbon Monoxide: Results for 126 United States Urban Counties, 1999–2005 , 2009, Circulation.

[36]  M. Inoue,et al.  Perceived Level of Life Enjoyment and Risks of Cardiovascular Disease Incidence and Mortality: The Japan Public Health Center–Based Study , 2009, Circulation.

[37]  A. Peters,et al.  Air Temperature and the Occurrence of Myocardial Infarction in Augsburg, Germany , 2009, Circulation.

[38]  J. Manson,et al.  Plasma Vitamin B6 and Risk of Myocardial Infarction in Women , 2009, Circulation.

[39]  Terho Lehtimäki,et al.  Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study , 2009, Circulation.

[40]  M. Pencina,et al.  Longitudinal Tracking of Left Ventricular Mass Over the Adult Life Course: Clinical Correlates of Short- and Long-Term Change in the Framingham Offspring Study , 2009, Circulation.

[41]  O. Franco,et al.  Associations of Physical Activity With Inflammatory Factors, Adipocytokines, and Metabolic Syndrome in Middle-Aged and Older Chinese People , 2009, Circulation.

[42]  J. Albers,et al.  Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.

[43]  S. Cummings,et al.  Peripheral Arterial Disease Is Associated With Higher Rates of Hip Bone Loss and Increased Fracture Risk in Older Men , 2009, Circulation.

[44]  Y. Ohashi,et al.  Four Blood Pressure Indexes and the Risk of Stroke and Myocardial Infarction in Japanese Men and Women: A Meta-Analysis of 16 Cohort Studies , 2009, Circulation.

[45]  M. Nieminen,et al.  Prognostic Value of Changes in the Electrocardiographic Strain Pattern During Antihypertensive Treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE) , 2009, Circulation.

[46]  Abdullah Al Mamun,et al.  Associations of Gestational Weight Gain With Offspring Body Mass Index and Blood Pressure at 21 Years of Age: Evidence From a Birth Cohort Study , 2009, Circulation.

[47]  A. Khera,et al.  Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study , 2009, Circulation.

[48]  Udo Hoffmann,et al.  Pericardial Fat, Intrathoracic Fat, and Measures of Left Ventricular Structure and Function: The Framingham Heart Study , 2009, Circulation.

[49]  E. Benjamin,et al.  Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community , 2009, Circulation.

[50]  J. Gore,et al.  Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective , 2009, Circulation.

[51]  D. Levy,et al.  Relations of Matrix Remodeling Biomarkers to Blood Pressure Progression and Incidence of Hypertension in the Community , 2009, Circulation.

[52]  R. Ferrari,et al.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[53]  M. Nieminen,et al.  Abstract 2293: Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients: The LIFE Study , 2006 .

[54]  P. Ridker,et al.  Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study , 2007, BMJ : British Medical Journal.

[55]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[56]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[57]  P. Ridker,et al.  Awareness, Accuracy, and Predictive Validity of Self-Reported Cholesterol in Women , 2007, Journal of General Internal Medicine.

[58]  D. Levy,et al.  Pulse pressure and risk of new-onset atrial fibrillation. , 2007, JAMA.

[59]  A. Waldo.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future PrevalenceMiyasaka Y, Barnes ME, Gersh BJ, et al (Mayo Clinic, Rochester, Minn): Circulation 114:119–125, 2006§ , 2007 .

[60]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[61]  G. Mancia,et al.  Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? , 2006, Annals of Internal Medicine.

[62]  A. Waldo.  A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need. , 2006, American heart journal.

[63]  James B Seward,et al.  Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? , 2006, Journal of the American College of Cardiology.

[64]  Qi Jiang,et al.  Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator , 2005 .

[65]  J. Manson,et al.  Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial , 2005, JAMA.

[66]  J. Manson,et al.  Prospective Study of Body Mass Index and Risk of Stroke in Apparently Healthy Women , 2005, Circulation.

[67]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[68]  Douglas Packer,et al.  Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation.

[69]  T. Truelsen,et al.  Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). , 2004, The American journal of cardiology.

[70]  Roberto Pastor-Barriuso,et al.  Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure: An Evaluation of Their Joint Effect on Mortality , 2003, Annals of Internal Medicine.

[71]  David Keane,et al.  Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[72]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[73]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[74]  A. Pessina,et al.  Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. , 2003, Journal of the American College of Cardiology.

[75]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[76]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[77]  J. Buring,et al.  Development of Predictive Models for Long-Term Cardiovascular Risk Associated With Systolic and Diastolic Blood Pressure , 2002, Hypertension.

[78]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[79]  N. Cook,et al.  Baseline characteristics of participants in the Women's Health Study. , 2000, Journal of women's health & gender-based medicine.

[80]  J. Manson,et al.  β-Carotene Supplementation and Incidence of Cancer and Cardiovascular Disease: the Women's Health Study. , 1999, Journal of the National Cancer Institute.

[81]  J. Manson,et al.  Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. , 1999, Journal of the National Cancer Institute.

[82]  D. Webb,et al.  Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. , 1998, Circulation.

[83]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[84]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[85]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[86]  R B D'Agostino,et al.  Secular trends in the prevalence of atrial fibrillation: The Framingham Study. , 1996, American heart journal.

[87]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[88]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[89]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[90]  S. Vaziri,et al.  Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.

[91]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[92]  W. Willett,et al.  Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. , 1986, American journal of epidemiology.

[93]  M. Shipley,et al.  Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. , 1985, British medical journal.

[94]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[95]  D. Cox.  Regression Models and Life-Tables , 1972 .